This current study investigated the role of MDM2, an oncogene first identified in mice, and showed that not only was its expression correlated with disease-free survival in clinical samples, but the overexpression of MDM2 enhanced the invasion and motility properties of two breast cancer cell lines in vitro. This evidence concerns the gene MDM2 and breast carcinoma.